FDA Approves Unknown Drug — TEVA PHARMS USA
Teva Pharmaceuticals USA has received approval for Nifedipine Extended-Release, a decision expected to intensify generic competition in the cardiovascular market and put pressure on branded rivals to maintain market share.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day